Cargando…
Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension
High-dose calcium channel blocker (CCB) shows strong blood pressure (BP) lowering effect. Currently available of controlled-release (CR) nifedipine 80 mg per day clinical data are limited to monotherapy and short-term or long-term retrospective studies. We report the safety and efficacy results of a...
Autores principales: | Shimamoto, Kazuaki, Kimoto, Masafumi, Matsuda, Yoshimi, Asano, Kozue, Kajikawa, Mariko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598367/ https://www.ncbi.nlm.nih.gov/pubmed/25876832 http://dx.doi.org/10.1038/hr.2015.54 |
Ejemplares similares
-
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
por: Capdevila, Jaume, et al.
Publicado: (2022) -
Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension
por: Shimizu, Yuji, et al.
Publicado: (2012) -
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension
por: Higaki, Jitsuo, et al.
Publicado: (2017) -
Nifedipine–pyrazine (2/1)
por: Schultheiss, Nate, et al.
Publicado: (2010) -
Livedoid Dermatitis Treated With Nifedipine
por: Wheless, Lee, et al.
Publicado: (2016)